Literature DB >> 17154414

Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes.

Jenny Odeberg1, Nina Wolmer, Scott Falci, Magnus Westgren, Erik Sundtröm, Ake Seiger, Cecilia Söderberg-Nauclér.   

Abstract

Human cytomegalovirus (HCMV) is the most common cause of congenital infections in developed countries, with an incidence varying between 0.5-2.2%. Such infection may be the consequence of either a primary infection or reactivation of a latent infection in the mother and the outcome may vary from asymptomatic to severe brain disorders. Moreover, infants that are asymptomatic at the time of birth may still develop neurologic sequelae at a later age. Our hypothesis is that infection of stem cells of the central nervous system by HCMV alters the proliferation, differentiation or migration of these cells, and thereby gives rise to the brain abnormalities observed. We show that infection of human neural precursor cells (NPCs) with the laboratory strain Towne or the clinical isolate TB40 of HCMV suppresses the differentiation of these cells into astrocytes even at an multiplicity of infection (MOI) as low as 0.1 (by 33% and 67%, respectively). This inhibition required active viral replication and the expression of late HCMV proteins. Infection as late as 24 hr after the onset of differentiation, but not after 72 hr, also prevented the maturation of infected cultures. Furthermore, in cultures infected with TB40 (at an MOI of 1), approximately 54% of the cells were apoptotic and cell proliferation was significantly attenuated. Clearly, HCMV can reduce the capacity of NPCs to differentiate into astrocytes and this effect may provide part of the explanation for the abnormalities in brain development associated with congenital HCMV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17154414     DOI: 10.1002/jnr.21144

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  42 in total

1.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

2.  Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.

Authors:  Kristine Dziurzynski; Jun Wei; Wei Qiao; Mustafa Aziz Hatiboglu; Ling-Yuan Kong; Adam Wu; Yongtao Wang; Daniel Cahill; Nicholas Levine; Sujit Prabhu; Ganesh Rao; Raymond Sawaya; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2011-04-13       Impact factor: 12.531

3.  Human Cytomegalovirus Infection Dysregulates the Localization and Stability of NICD1 and Jag1 in Neural Progenitor Cells.

Authors:  Xiao-Jun Li; Xi-Juan Liu; Bo Yang; Ya-Ru Fu; Fei Zhao; Zhang-Zhou Shen; Ling-Feng Miao; Simon Rayner; Stéphane Chavanas; Hua Zhu; William J Britt; Qiyi Tang; Michael A McVoy; Min-Hua Luo
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 4.  Gammadelta T cells as immune effectors against high-grade gliomas.

Authors:  Lawrence S Lamb
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

5.  Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA.

Authors:  Jean-Philippe Belzile; Thomas J Stark; Gene W Yeo; Deborah H Spector
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

6.  Viral mitochondria-localized inhibitor of apoptosis (UL37 exon 1 protein) does not protect human neural precursor cells from human cytomegalovirus-induced cell death.

Authors:  Richard L Hildreth; Matthew D Bullough; Aiping Zhang; Hui-Ling Chen; Philip H Schwartz; David M Panchision; Anamaris M Colberg-Poley
Journal:  J Gen Virol       Date:  2012-08-08       Impact factor: 3.891

Review 7.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

8.  Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.

Authors:  Ninib Baryawno; Afsar Rahbar; Nina Wolmer-Solberg; Chato Taher; Jenny Odeberg; Anna Darabi; Zahidul Khan; Baldur Sveinbjörnsson; O-M FuskevÅg; Lova Segerström; Magnus Nordenskjöld; Peter Siesjö; Per Kogner; John Inge Johnsen; Cecilia Söderberg-Nauclér
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

9.  Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders.

Authors:  Ivan Gentile; Emanuela Zappulo; Maria Pia Riccio; Sandro Binda; Laura Bubba; Laura Pellegrinelli; Domenico Scognamiglio; Francesca Operto; Lucia Margari; Guglielmo Borgia; Carmela Bravaccio
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

10.  Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells.

Authors:  Min Hua Luo; Holger Hannemann; Amit S Kulkarni; Philip H Schwartz; John M O'Dowd; Elizabeth A Fortunato
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.